We welcome requests for further information or interviews.
Robert Robinson Avenue
The Oxford Science Park
Circassia is a world-class specialty pharmaceutical business focused on respiratory disease. Circassia sells its novel, market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom and Germany, and in a wide range of other countries through its network of partners. In 2017, the Company established a collaboration with AstraZeneca in the US in which it promotes the chronic obstructive pulmonary disease (COPD) treatment Tudorza®, and has the commercial rights to the COPD product Duaklir®*, which was recently filed for approval.
*The Duaklir® trademark is registered in the United States; the mark is not currently approved for use by the FDA.
Circassia Pharmaceuticals plc may use your personal information to contact you by email, telephone or post to respond to your query.